Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: Epidemiology, Etiopathogenesis, Clinical Presentation, Treatment – A Systematic Review
June 2026
in “
Quality in Sport
”
congenital adrenal hyperplasia 21-hydroxylase deficiency adrenal steroidogenesis cortisol aldosterone adrenal androgens 17OHP hydrocortisone fludrocortisone CRF receptor antagonists ACTH secretion inhibitors gene therapy CAH cortisol deficiency aldosterone deficiency adrenal crisis 17-hydroxyprogesterone cortisol replacement fludrocortisone acetate
Studysummary This study reviewed the current understanding of congenital adrenal hyperplasia from 21-hydroxylase deficiency, highlighting the impact of universal newborn screening in reducing mortality and discussing ongoing treatment challenges and future therapeutic prospects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on apcz.umk.pl →